samsung biologics 207940 Algorithm Investment Report

1. Performance Analysis of Algorithm (consolidated) 207940 Date
Period 3 months 100-m won
2018.12 2019.12 2020.12 Average 2020.12 2021.03 2021.06 2021.09 2021.12 2022.03
IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con)
Sales 5,358 7,016 11,648 8,007 3,753 2,608 4,122 4,507 4,567 4,793 3,748
O-profit 557 917 2,928 1,467 926 743 1,668 1,674 1,482 1,818 1,253
N-income 2,241 2,029 2,410 2,227 962 610 1,215 1,318 960 1,384 1,026
O-rate 10.4 13.1 25.1 16.2 24.7 28.5 40.5 37.1 32.5 37.9 32.7
N-rate 41.8 28.9 20.7 30.5 25.6 23.4 29.5 29.2 21.0 28.9 26.9
ROE 5.4 4.7 5.2 5.1 8.4 6.8 8.4 8.6 8.0 8.5 8.1
Debt-ratio 43.9 35.8 39.7 39.8 39.7 39.0 38.3 54.6 61.7 69.8 42.9
Quick-ratio 176.7 127.9 182.8 162.5 182.8 172.9 161.5 180.5 203.3 231.3 174.4
reserve-ratio 2,416.6 2,539.2 2,684.9 2,546.9 2,684.9 2,721.8 2,795.3 2,875.0 2,945.0 3,018.6 2,769.3
EPS 3,387 3,067 3,642 3,365 1,454 922 1,836 1,992 1,452 2,058 1,551
BPS 62,805 65,813 69,505 66,041 69,505 70,428 72,259 74,254 75,909 77,602 71,612
Dividends 0 0 0 0
Major
Financial
Information
Recent Annual Performance Recent quarterly performance Estimate
Average
2022-02-19
Gap
(Indication /
stock)
Color
High price ~ 8 %
High mid ~ -7 %
Mid ~ -22 %
Low mid ~ -37 %
Low price ~ -51 %
Sell
367,828 W 367,828 W 0 W
Industrial name of the company
The number of
All industries
Algorithm
Industry ranking
Total number of
listed companies
Algorithm
company ranking
Investment
opinion
Pharmaceutical 79 41 3,392 821
703,580 W 703,580 W 591,663 W
591,663 W 591,663 W 479,745 W Evaluation
815,498 W 815,498 W~ 703,580 W
757,000 W
37.4
479,745 W 479,745 W 367,828 W
High price
Indication price Range Current stock price Company score
367,828원
479,745원
591,663원
703,580원
815,498원
High price
757,000원
-51%
-37%
-22%
-7%
7.7%
-60%
-50%
-40%
-30%
-20%
-10%
0.%
10.%
20.%
0W
100,000W
200,000W
300,000W
400,000W
500,000W
600,000W
700,000W
800,000W
900,000W
Low price Low mid Mid High mid High price
Indication price chart (Consolidated)
Indication price
samsung biologics
Gap
samsung biologics

2. [Price for scheduled purchasing]
Arbitrarily made
Algorithm stocks Trading Strategies (consolidated) 207940 Date
Period
Gap
(Indication /
stock)
Color
low price 367,828 W 367,828 W ~ 0 W -51 % 207,286 W 1
Low mid 479,745 W 479,745 W ~ 367,828 W -37 % 147,675 W 0
Mid 591,663 W 591,663 W ~ 479,745 W -22 % 88,064 W 0
High mid 703,580 W 703,580 W ~ 591,663 W -7 % 28,453 W 0
Suggested Purchase
Amount 403,204 W
Number of stocks
purchased 1
Indication price Range Buying / Selling Buying / Selling [Stocks]
High price 815,498 W 815,498 W~ ~ 703,580 W 8 % -31,158 W -0
2022-02-19
3 months
Current stock price Evaluation
Stock price rise
probability score
Investment opinion Prospective purchase amount
757,000 W High price 34.1 Sell 2,000,000 W
43.0 35.4 42.8 52.5 43.7 41.1
2021.09.23 2021.10.25 2021.11.22 2021.12.20 2022.01.18 2022.02.18
Stock price rise
probability score
A Sector 51.5 45.4 46.8 45.9 41.8 43.5
34.1
B Sector 34.6 25.4 38.8 45.9 45.6 38.8
Total average
2021.11.22 2021.12.20 2022.01.18 2022.02.18
Total of
increase rate
Total score
A Sector -14 % 3 % -2 % -10 % 4 %
-2 % 45.0
B Sector -36 % 34 % 16 % -1 % -18 %
Total average -22 % 17 % 18 % -20 % -6 %
2021.10.25
51
45 47 46
42 44
35
25
39
46 46
39
43
35
43
53
44 41
0
10
20
30
40
50
60
2021.09.23 2021.10.25 2021.11.22 2021.12.20 2022.01.18 2022.02.18
Stock price rise probability score
A sector
B sector
Total average
-14%
3%
-2%
-10%
4%
-36%
34%
16%
-1%
-18%
-22%
17% 18%
-20%
-6%
-40%
-30%
-20%
-10%
0%
10%
20%
30%
40%
2021.10.25 2021.11.22 2021.12.20 2022.01.18 2022.02.18
Increase rate of stock price rise
A sector
B sector
Total average
samsung biologics

3. 정보와
완전
정보
결
투자판단
있습니
위배
무단으
숙지하
Compliance notice
① The information provided by The Algorithm Company Analysis
Consulting is obtained through reliable data and information and
The Algorithm Company Analysis Program (TACAP), but its
accuracy or completeness are not guaranteed. Furthermore, it may
change over time.Therefore, we are not legally responsible for the
results of the data provided by The Algorithm Company Analysis
Consulting because of information errors or omissions.
② The Algorithm Company Analysis Consulting and all the
information provided on it site are reference materials for
investment decisions and the final responsibility of investment is
up to users utilizing this information.
③ The Algorithm Company Analysis Consulting and its site do not
do anything that violates the related laws such as discretionary
transaction.
④ Users can not reallocate and recycle the information provided by
The Algorithm Company Analysis Consulting firm let alone the
information provided by its Site.
⑤ Be sure to know about application period of this algorithm
analysis report in order to improve its accuracy.
Tel : 070 - 4667 - 5009 Email : tacac@tacac.co.kr
Homepage : tacac.co.kr Blog : tacac.blog.me
SERVICES
M&A, IPO, RECOVER, CORPORATE RESTRUCTURING, MANAGEMENT OF
TECHNOLOGY, BUSINESS STRATEGY, FAMILY BUSINESS
Request : http://tacac.co.kr/?page_id=1374
①
Consulting is o
The Algorithm
accuracy or com
change over tim
results of the d
Consulting bec
②
information pr
investment dec
up
③
do anything th
transaction.
④
The Algorithm
information pr
⑤
analysis report